Changes in treatment of community-onset Clostridioides difficile infection after release of updated guidelines, Atlanta, Georgia, 2018

Updated Clostridioides difficile infection (CDI) guidelines published in 2018 recommend vancomycin as first-line treatment. Of 833 community-onset CDI cases in metropolitan Atlanta, Georgia in 2018, over half did not receive first-line treatment, although guideline adherence increased over the year....

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Anaerobe Ročník 70; s. 102364
Hlavní autoři:	Adelman, Max W., Goodenough, Dana, Sefton, Samantha, Mackey, Carolyn, Thomas, Stepy, Fridkin, Scott K., Woodworth, Michael H.
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	England Elsevier Ltd 01.08.2021
Témata:	Adult Aged Anti-Bacterial Agents - standards Anti-Bacterial Agents - therapeutic use Clostridioides difficile - drug effects Clostridioides difficile - physiology Clostridioides difficile infection Clostridium difficile Clostridium Infections - drug therapy Clostridium Infections - microbiology Cohort Studies Community-Acquired Infections - drug therapy Community-Acquired Infections - microbiology Female Georgia Guideline-adherent treatment guidelines Guidelines as Topic Humans Male Metronidazole Metronidazole - standards Metronidazole - therapeutic use Middle Aged Vancomycin Vancomycin - standards Vancomycin - therapeutic use Georgia Clostridioides difficile infection Metronidazole Vancomycin Guideline-adherent treatment
ISSN:	1075-9964, 1095-8274, 1095-8274
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!